American Medical Response Inc.

Medgenics Announces Encouraging Preliminary Data for Phase I/II Clinical Trial of EPODURE in Renal Anemia

November 3rd, 2008

Medgenics (AIM:MEDG), is pleased to announce encouraging preliminary data for its Phase I/II clinical trial.
The landmark Phase I/II clinical trial of Medgenics’ EPODURE Biopump, for providing sustained treatment of anemia in subjects with chronic kidney disease, is underway. The current trial is designed to assess the safety and efficacy of the EPODURE Biopump in providing [...]

Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers

November 2nd, 2008

Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS - News) announced today the results of a Phase I clinical trial of ANA598 in healthy volunteers and additional preclinical data that support ANA598 as one of the leading non-nucleoside polymerase inhibitors currently in development for the treatment of HCV. These results are being presented at the 59th Annual Meeting [...]

Related Tags: Anadys Pharmaceuticals Inc. biopharmaceutical biotechnology California cancer chronic HCV chronic hepatitis C cirrhosis drug therapy Fibrosis genotype HCV infection HCV therapies hepatitis C Indiana inflammation liver cancer Liver Diseases liver failure pharmaceutical San Francisco Securities and Exchange Commission thumb site transplantation treatment of cancer treatment of HCV United States US Food and Drug Administration

Related Search: indiana stat university on line nursing

Gilead Announces Two-Year Data from Pivotal Phase III Studies Evaluating Viread(R) for Chronic Hepatitis B

November 2nd, 2008

Gilead Sciences, Inc. (Nasdaq:GILD - News) today announced the presentation of two-year (96-week) data from two Phase III pivotal clinical trials, Studies 102 and 103, evaluating the safety and efficacy of once-daily Viread® (tenofovir disoproxil fumarate) among adult patients with chronic hepatitis B virus (HBV) infection. These data will be presented during oral sessions at [...]

Related Tags: abdominal pain acute renal failure American Association for the Study of Liver Diseases antibodies antiretroviral therapy Australia back pain biopharmaceutical California Canada carcinoma chronic hepatitis B cirrhosis Clichy depression Diarrhea dizziness Europe Fanconi syndrome fatigue food Foster City France Gilead Sciences Inc. HBV therapy HBV treatment headache hepatitis Hepatitis B hepatitis B therapies hepatitis B therapy Hepsera Hepsera-to-Viread HIV HIV infection Immune reconstitution syndrome intent-to-treat analysis algorithm investigational product Jenny Heathcote Lactic acidosis lamivudine liver cancer liver disease Liver Diseases nasopharyngitis nausea North America osteopenia pain Patrick Marcellin rash San Francisco skin rash tenofovir disoproxil fumarate transplantation treatment of HIV U.S. Centers for Disease Control and Prevention U.S. Securities and Exchange Commission United States University of Toronto US Food and Drug Administration Viread viremia

Related Search: nursing school in perth australia NCSBN our customers viread hepatitis b baby

Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers

November 1st, 2008

Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS - News) announced today the results of a Phase I clinical trial of ANA598 in healthy volunteers and additional preclinical data that support ANA598 as one of the leading non-nucleoside polymerase inhibitors currently in development for the treatment of HCV. These results are being presented at the 59th Annual Meeting [...]

Related Tags: American Association for the Study of Liver Diseases Anadys Pharmaceuticals Inc. biopharmaceutical California cancer chronic HCV chronic hepatitis C cirrhosis drug therapy Fibrosis genotype HCV infection hepatitis C Indiana inflammation liver cancer Liver Diseases liver failure San Francisco thumb site transplantation treatment of cancer treatment of HCV United States US Food and Drug Administration

Related Search:

Gilead Announces Two-Year Data from Pivotal Phase III Studies Evaluating Viread(R) for Chronic Hepatitis B

November 1st, 2008

Gilead Sciences, Inc. (Nasdaq:GILD - News) today announced the presentation of two-year (96-week) data from two Phase III pivotal clinical trials, Studies 102 and 103, evaluating the safety and efficacy of once-daily Viread® (tenofovir disoproxil fumarate) among adult patients with chronic hepatitis B virus (HBV) infection. These data will be presented during oral sessions at [...]

Related Tags: abdominal pain acute renal failure American Association for the Study of Liver Diseases antibodies antiretroviral therapy Australia back pain biopharmaceutical California Canada carcinoma chronic hepatitis B cirrhosis Clichy depression Diarrhea dizziness Europe Fanconi syndrome fatigue food Foster City France Gilead Sciences Inc. HBV therapy HBV treatment headache hepatitis Hepatitis B hepatitis B therapies hepatitis B therapy Hepsera Hepsera-to-Viread HIV HIV infection Immune reconstitution syndrome intent-to-treat analysis algorithm investigational product Jenny Heathcote Lactic acidosis lamivudine liver cancer liver disease Liver Diseases nasopharyngitis nausea North America osteopenia pain Patrick Marcellin rash San Francisco skin rash tenofovir disoproxil fumarate transplantation treatment of HIV U.S. Centers for Disease Control and Prevention U.S. Securities and Exchange Commission United States University of Toronto US Food and Drug Administration Viread viremia

Related Search: job and hepatitis b in dubai

GlobeImmune Hepatitis C Therapeutic Vaccine, GI-5005, Doubles Viral Clearance and Increases RVR Rates in Phase 2 Clinical Trial

November 1st, 2008

Four-week Phase 2 clinical trial data show that GI-5005, GlobeImmune’s hepatitis C virus (HCV) targeted molecular immunogen (Tarmogen®), doubled viral clearance overall and in all major subgroups and doubled the rapid virologic response (RVR) rate in naïve patients with high viral load. The study compared GI-5005 plus standard of care (SOC) — pegylated-interferon plus ribavirin [...]

Related Tags: American Association for the Study of Liver Diseases cancer cancers chronic HCV chronic hepatitis C colorectal cancer David Apelian Duke University genotype GlobeImmune Inc. hepatitis C infectious diseases John G. McHutchison Liver Diseases pancreas cancer small cell lung cancer therapies for HCV treatment of cancer treatment of hepatitis C treatment of pancreas cancer

Related Search: dubai hepatitis c yeast HCV vaccine David Apelian email globeimmune com GI-5005 hepatitis C vaccine

EMSC Enters Anesthesiology Outsourcing Market

August 8th, 2008

Emergency Medical Services Corporation (NYSE: EMS - News) (the “Company”) today announced that it has entered into an agreement to acquire the management services entity of Clinical Partners, P.A. (CPPA), a provider of anesthesiology services, as well as an associated billing company. Upon closing, the management entity will enter into a long-term agreement to provide [...]

Related Tags: ambulance services American Medical Response Inc. anesthesia services anesthesiology practice management services anesthesiology services Clinical Partners Colorado EmCare Holdings Inc. EmCare Inc. Emergency Medical Services Corporation Greenwood Village Harold Bolnick healthcare facilities healthcare transportation services segment hospitalist services Jim McKinney Management Change related management services United States William A. Sanger

Related Search: harold bolnick outsourcing for online statements jim mckinney healthcare POST FOR NURSING ASSISTANT IN Emergency Medical Services Jim McKinney Healthcare clinical partners emcare anesthesia practice management www yournursing com emcare and Clinical partners

EMSC Enters Anesthesiology Outsourcing Market

August 7th, 2008

Emergency Medical Services Corporation (NYSE: EMS - News) (the “Company”) today announced that it has entered into an agreement to acquire the management services entity of Clinical Partners, P.A. (CPPA), a provider of anesthesiology services, as well as an associated billing company. Upon closing, the management entity will enter into a long-term agreement to provide [...]

Related Tags: ambulance services American Medical Response Inc. anesthesia services anesthesiology practice management services anesthesiology services Clinical Partners Colorado EmCare Holdings Inc. EmCare Inc. Emergency Medical Services Corporation Greenwood Village Harold Bolnick healthcare facilities healthcare transportation services segment hospitalist services Jim McKinney Management Change related management services United States William A. Sanger

Related Search: anaesthesiology nursing in ireland federal medical services outsourcing emcare & anesthesia bolnick anesthesia hospital outsourcing anesthesiology anesthesiologists market HAROLD BOLNICK agreement to provide management services assisted living Harold Bolnick